Loading ETF profile…
The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 6.25% | $11.90M |
| LLY | ELI LILLY & CO | 5.22% | $9.94M |
| COGT | COGENT BIOSCIENCES INC | 4.91% | $9.36M |
| NOVN.SW | NOVARTIS AG | 4.11% | $7.83M |
| RHHBY | ROCHE HOLDING AG | 3.91% | $7.45M |
| LEGN | LEGEND BIOTECH CORP | 3.71% | $7.07M |
| MRK | MERCK & CO INC | 3.60% | $6.85M |
| BMY | BRISTOL-MYERS SQUIBB CO | 3.32% | $6.31M |
| AZN.L | ASTRAZENECA PLC | 3.09% | $5.89M |
| JNJ | JOHNSON & JOHNSON | 3.08% | $5.86M |
| ABBV | ABBVIE INC | 3.03% | $5.77M |
| IMNM | IMMUNOME INC | 2.96% | $5.64M |
| EXEL | EXELIXIS INC | 2.76% | $5.26M |
| NUVL | NUVALENT INC | 2.67% | $5.09M |
| CGON | CG ONCOLOGY INC | 2.66% | $5.07M |
| IDYA | IDEAYA BIOSCIENCES INC | 2.61% | $4.97M |
| AMGN | AMGEN INC | 2.55% | $4.86M |
| CELC | CELCUITY INC | 2.20% | $4.19M |
| BBIO | BRIDGEBIO PHARMA INC | 2.20% | $4.19M |
| GMAB | GENMAB A/S | 2.17% | $4.13M |
| RLAY | RELAY THERAPEUTICS INC | 1.83% | $3.49M |
| ERAS | ERASCA INC | 1.75% | $3.34M |
| ONC | BEONE MEDICINES LTD | 1.75% | $3.34M |
| ELVN | ENLIVEN THERAPEUTICS INC | 1.62% | $3.09M |
| ZLAB | ZAI LAB LTD | 1.49% | $2.84M |